Chromatin and Epigenetics

Overview

Conference Overview

Epigenetics refers to heritable change in gene expression that does not involve changes to the underlying DNA sequence. At least three systems including DNA methylation, histone modifications and non-coding RNAs (ncRNA) are considered to play fundamental roles in epigenetic regulation. Research over the last two decades has uncovered the role of epigenetics in a variety of human disorders and fatal diseases. Moreover influence of age, environment, lifestyle, and disease state on epigenetic states is being increasingly appreciated and actively studied.

This conference provides an international forum for cutting edge research in chromatin and epigenetics. It provides the “focal hub” for people to present their research and exchange ideas in a European venue. Renowned speakers will cover the latest advances in the field, including chromatin regulation, chromatin dynamics, signalling to chromatin, nuclear architecture and dynamics, developmental epigenetics, epigenomics, epigenetics and human diseases, genome stability, environmental epigenetics, and transgenerational inheritance.

Session Topics

• Epigenetic reprogramming
• Developmental epigenetics
• Different states of chromatin
• Histone modifications, RNA and metabolism
• Transcriptional and posttranscriptional regulation
• Nuclear architecture
• Chromatin and its variants in disease

Speakers

Asifa Akhtar

Max Planck Institute of Immunobiology and Epigenetics

Germany

Geneviève Almouzni

Institut Curie

France

Wendy Bickmore

The University of Edinburgh

UK

Andrea Brand

The Gurdon Institute, University of Cambridge

UK

Howard Y. Chang

Stanford University

USA

L. Stirling Churchman

Harvard Medical School

USA

Ibrahim Cissé

Massachusetts Institute of Technology

USA

Xavier Darzacq

University of California, Berkeley

USA

Caroline Dean

John Innes Centre

UK

Joseph R. Ecker

HHMI & The Salk Institute for Biological Studies

USA

Emma Farley

University of California, San Diego

USA

Anne Ferguson-Smith

University of Cambridge

UK

Polly Fordyce

Stanford University

USA

Eileen Furlong

EMBL Heidelberg

Germany

Edith Heard

EMBL Heidelberg

Germany

Steven Henikoff

Fred Hutchinson Cancer Research Center

USA

Gary H. Karpen

UC Berkeley, Lawrence Berkeley National Lab

USA

Jean-Christophe Marine

VIB-KU Leuven Center for Cancer Biology

Belgium

Jean-Christophe Marine

VIB-KU Leuven Center for Cancer Biology

Belgium

Ana Pombo

Max Delbrück Center for Molecular Medicine

Germany

Chris Ponting

The University of Edinburgh

UK

Wolf Reik

Babraham Institute

UK

Amos Tanay

Weizmann Institute of Science

Israel

Igor Ulitsky

Weizmann Institute of Science

Israel

Fred Winston

Harvard Medical School

USA

Scientific Organisers

Asifa Akhtar

Max Planck Institute of Immunobiology and Epigenetics

Germany

Geneviève Almouzni

Institut Curie

France

L. Stirling Churchman

Harvard Medical School

USA

Ana Pombo

Max Delbrück Center for Molecular Medicine

Germany

Chris Ponting

The University of Edinburgh

UK

Conference Organisers

Tim Nürnberger

EMBL Heidelberg

Germany

Programme